Related MeSH Hierarchy (4)
Diseases [C] » Neoplasms [C04] » Neoplasms by Site » Digestive System Neoplasms » Biliary Tract Neoplasms » Bile Duct Neoplasms
Diseases [C] » Digestive System Diseases [C06] » Biliary Tract Diseases » Bile Duct Diseases » Bile Duct Neoplasms
Diseases [C] » Digestive System Diseases [C06] » Biliary Tract Diseases » Biliary Tract Neoplasms » Bile Duct Neoplasms
Diseases [C] » Digestive System Diseases [C06] » Digestive System Neoplasms » Biliary Tract Neoplasms » Bile Duct Neoplasms
Description
Tumors or cancer of the BILE DUCTS. MeSH
Hierarchy View
Subtype Terms (1)
Common Bile Duct Neoplasms
2 approved drugs
Approved Indicated Drugs (1)
Phase 4 Indicated Drugs (2)
Phase 2 Indicated Drugs (84)
Other Experimental Indicated Drugs (8)
Organization Involved with Phase 4 Indications (1)
Organization Involved with Phase 3 Indications (16)
Organization Involved with Phase 2 Indications (54)
Cantonal Hospital of St. Gallen
Case Western Reserve University
Chinese University of Hong Kong
Eastern Hepatobiliary Surgery Hospital
Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)
National Institutes of Health (NIH)
Simcere Pharmaceutical Co., Ltd
State University of New York, Buffalo
Swiss Group for Clinical Cancer Research
The University of Texas, Dallas
University of California, Davis
Organization Involved with Phase 1 Indications (11)
Organization Involved with Other Experimental Indications (4)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
